
















Newcastle University ePrints - eprint.ncl.ac.uk 
 
De M, Rana S, Akpinar H, Miranda OR, Arvizo RR, Bunz UHF, Rotello VM. 
Sensing of proteins in human serum using conjugates of nanoparticles and 
green fluorescent protein.  




This is the authors’ accepted manuscript of an article that was published in its final definitive form by 
Nature Publishing Group, 2009. 
DOI link to article: 
https://doi.org/10.1038/nchem.334  
Date deposited:   
11/05/2018 
Sensing of Proteins in Human Serum using Nanoparticle-Green 
Fluorescent Protein Conjugates
MRINMOY DE1, SUBINOY RANA1, HANDAN AKPINAR1, OSCAR R. MIRANDA1, ROCHELLE 
R. ARVIZO1, UWE H. F. BUNZ2, and VINCENT M. ROTELLO*,1
1Department of Chemistry, University of Massachusetts, 710 North Pleasant Street, Amherst, MA 
01003, USA
2School of Chemistry and Biochemistry, Georgia Institute of Technology, 770 State Street, 
Atlanta, Georgia 30332, USA
Abstract
There is a direct correlation between protein levels and disease states in human serum making it an 
attractive target for sensors and diagnostics. However this is made challenging because serum 
features more than 20,000 proteins with an overall protein content of greater than 1 mM. Here we 
report a hybrid synthetic-biomolecule based sensor that uses green fluorescent protein-
nanoparticle arrays to detect proteins at biorelevant concentrations in both buffer and human 
serum. Distinct and reproducible fluorescence response patterns were obtained from five serum 
proteins (human serum albumin, immunoglobulin G, transferrin, fibrinogen and α-antitrypsin) in 
buffer and when spiked into human serum. Using linear discriminant analysis we identified these 
proteins with an identification accuracy of 100% in buffer and 97% in human serum. The arrays 
were also able to discriminate between different concentrations of the same protein as well as a 
mixture of different proteins in human serum.
The rapid and efficient identification of protein imbalances in serum (the clear yellowish 
solution obtained after removal of blood cells and clotting factors from whole blood), is an 
important tool for disease diagnosis1, 2. It contains >20,000 different proteins ranging from 
50 gL−1 (serum albumin)3, 4 to less than 1 ngL−1 (troponin)5, with an overall protein 
concentration of ~1 mM. The relative and absolute level of these proteins is directly related 
to specific disease states. Two different approaches have been employed for serum-based 
diagnostics: specific recognition of biomarkers and techniques that focus on the overall 
levels of serum proteins. Proteins present in small quantities are specifically detected by 
monoclonal antibodies. With this method each monoclonal antibody has to be developed and 
can detect only one specific protein6,7, and technical difficulties in regard to quantification 
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are significant8. Alternatively, electrophoresis is the current tool of choice in clinics for 
overall serum analysis, despite the relative insensitivity, lack of resolution, and difficulty in 
quantification of this method9. Better resolution is provided by 2D-SDS-PAGE 
electrophoresis. However, quantification and slow analysis times remain an issue. Mass 
spectrometry (SELDI) likewise provides a potentially powerful tool10, 11, but the expensive 
instrumentation, low throughput and the limited dynamic range restrict its applicability. The 
indicator displacement assay (IDA) has also been used to detect the key biological targets 
(e.g. heparin,12 inorganic phosphate13) in serum. In spite of the convenience, sensitivity 
and promptness of these systems, the specificity of the sensor for particular analytes limits 
its applicability in multiple analyte detection in undiluted serum.
A “chemical nose/tongue” strategy14,15 provides an alternative strategy to the above 
methods for protein sensing. In the “nose” approach, differential interactions of analytes 
with a receptor array generate a pattern that is used for identification. A variety of scaffolds 
have been employed for array-based sensing of proteins, including oligopeptide-
functionalized resins16, substituted porphyrins17, polymers18, 19 and synthetic polymer-
nanoparticle systems20, 21. While highly effective at identifying proteins, these systems 
generally feature high limits of detection (generally 8–40 μM) and require a large number of 
detector elements relative to the number of proteins sensed. Moreover, these methods have 
not been applied to sensing in challenging matrices such as biofluids.
To provide a more effective system suitable for protein sensing in serum, we created hybrid 
synthetic-biomolecular sensor elements. In the sensing process an array of green fluorescent 
protein (GFP)-nanoparticle (NP) complexes generates a signature that can be employed to 
identify proteins in human serum. Compared to our previous sensor array using polymers, 
the biocompatibility of both the nanoparticles and GFP allows us to use this system without 
affecting the target protein conformation during their detection22,23. In addition, the GFP-
NP conjugate mimics protein-protein surface interactions, which is instrumental in reaching 
much lower detection limits and thus enabling detection of biomedically relevant changes in 
protein concentration in undiluted human serum.
Our sensing strategy relies on the electrostatic complementarity between GFP and the NPs. 
GFP is a beta barrel shaped marker protein that is negatively charged at physiological 
conditions (3.0 diameter × 4.0 nm length, MW = 27 KDa, pH 7.4, pI = 5.92) 24, 25, with an 
excitation peak at 490 nm and emission peak at 510 nm. Due to their positive charges, the 
gold NPs complex the anionic GFP, resulting in fluorescence quenching. We hypothesized 
that in the presence of analyte proteins the binding equilibrium between GFP and NP would 
be altered due to competitive binding, thus modulating the fluorescence response (Figure 
1b). The fluorescence response can be positive or negative depending on the binding affinity 
of analyte proteins towards NPs and GFP. A higher affinity of the protein to NPs produces 
positive response, while a higher affinity to GFP generates a negative response as a result of 
analyte protein-GFP aggregation (Figure S17). To confirm this hypothesis, five cationic gold 
NPs (NP1–NP5) were fabricated as sensor elements. In addition to their cationic charges, 
the ligand shells of these NPs differ in hydrophobicity, aromaticity, and hydrogen bonding 
ability (Figure 1a).
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Roughly 20 serum proteins with different charge and molecular weights constitute 99% by 
mass of the serum protein content26. We choose five of the most abundant serum proteins 
for our studies: albumin, immunoglobulin G (IgG), transferrin, fibrinogen and α-antitrypsin 
(Table 1).
Preliminary studies were performed in buffer. We optimized the binding ratio between GFP 
and NPs (NP1–NP5) through fluorescence titration. The fluorescence of GFP was 
significantly quenched for all NPs and the change of fluorescence intensity against 
increasing NP concentrations was plotted (Figure S2). The complex stability constants (KS) 
and association stoichiometries (n) were obtained through nonlinear least-squares curve-
fitting analysis (Table S1)27. The variation in complex stabilities and the binding 
stoichiometry demonstrate the significant effect of head groups in NP-protein affinity.
Once the binding ratio that provided maximum quenching of fluorescence was determined, 
we tested the ability of our sensor to detect serum proteins in 5 mM sodium phosphate 
buffer using a solution of 100 nM of both NPs and GFP. Testing at varying protein 
concentrations demonstrated that complete differentiation of the five analyte proteins was 
obtained at 25 nM (Figure 2a).
Linear discriminant analysis (LDA) was used to quantitatively differentiate the fluorescence 
response patterns of the GFP-NP conjugates with the serum proteins28. LDA is a statistical 
technique that maximizes the ratio between-class variance to the within-class variance, 
allowing the differentiation of response patterns. We generated the fluorescence responses 
six times for each protein against the five GFP-NP conjugates for this purpose. After the 
analysis, four canonical factors were generated (91.5%, 6.8%, 1.2% and 0.5%) that represent 
linear combinations of the response matrices obtained from the fluorescence response 
patterns (5 GFP-NP conjugates × 5 proteins × 6 replicates). The 30 training cases (5 proteins 
× 6 replicates) are separated in five respective groups with 100% accuracy according to the 
jackknifed classification matrix derived from analysis of subsets of the datasets, and the 
most significant two factors are plotted in 2D (Figure 2b). This detection efficiency was 
validated through identification of unknowns from our training set, where a randomized set 
of the five proteins from the training set were identified with 97% accuracy (Table S6).
Protein sensing in human serum provides a far more demanding testbed than pure proteins in 
buffer solution. The high overall protein content (~1 mM, 71 mg/mL) and multianalyte 
nature of human serum generates a complex matrix that is challenging for sensor design. To 
provide a controlled model for testing our methodology, we spiked physiologically relevant 
concentrations of the above five proteins into commercially available human serum. We first 
optimized the concentration and ratio of GFP-NP conjugates. Because of the optical density 
of pure human serum, a higher concentration of GFP (250 nM) was required to get sufficient 
response. The titration data (Figure 3) indicates that saturation in fluorescence quenching 
was not observed even at a 8:1 NP/GFP ratio due to the presence of the other proteins in 
human serum that compete with GFP for NP binding. To provide reproducible quenching 
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and a high level of sensitivity, we used a particle concentration of 500 nM, corresponding to 
the inflexion point observed in the titration curves (Figure 3).
Using the conditions optimized above, 500 nM was the minimum amount of spiked analyte 
required for reproducible differentiation of the target proteins. We created a training matrix 
(5 GFP-NP conjugates × 5 proteins × 6 replicates) with GFP-NP conjugates and each of the 
proteins. Similar to the buffer studies, each of the proteins generated distinct fluorescence 
response. As before, these patterns were further subjected to LDA analysis, providing a 97% 
identification accuracy, as α-antitrypsin slightly overlaps with IgG. The four canonical 
factors are 76.9%, 20.3%, 2.7%, 0.1% and the plot of the first two factors with 95% 
confidence ellipses is presented in Figure 4b. We next tested the system against unknowns 
taken from the training set. Out of 30 samples 28 samples were correctly identified affording 
a 93% identification accuracy (see Table S7 for raw data). We identified target proteins in 
the complex serum matrix at physiologically relevant submicromolar concentrations. As a 
point of reference, we were able to detect and identify the analyte proteins between 0.06 to 
8.4% (by molarity) of total serum protein concentration (Table 2).
After successful detection of serum proteins in human serum, the next challenge arises from 
the detection of a protein at variable concentration level and in mixture with other proteins. 
One of the limitations of immunosensing as well as other approaches is the differentiation 
between the variable concentration levels of a single protein. To probe the ability of our 
system in this dimension, we performed spiking experiments with HSA and IgG at different 
concentrations (500 nM, 1 μM and 2 μM). We observed that the LDA plots for various 
concentrations are not random, but rather follow certain patterns and can be differentiated 
from each other for many concentrations (Figure 5a). Essentially, the responses from 
different concentrations form clusters around a common center which are distinct for each 
protein (Figure 5b).
After obtaining differentiation at varying level of protein concentration we continued our 
investigation towards the detection of mixture of proteins in serum. We mixed HSA and IgG 
in serum at 1:1 molar ratio with 250 nM each as well as 500 nM each and compared with 
500 nM of individual proteins. When subjected to the LDA analysis of the fluorescence 
responses, it shows that the canonical score plots revolve around the HSA and IgG plots and 
are clearly distinct (Figure 5c). Although we can discriminate the mixture of proteins at 
different concentration from each other, no correlation between the plots could be drawn 
since the complex equillibria among the serum proteins, GFP and NP make the system 
behave differently. However, these studies indicate that profiles of mixtures of proteins can 
be generated that could enable detection of disease states featuring altered levels of proteins.
In conclusion, a GFP-NP array combining synthetic and biological elements provides a 
highly sensitive array-based sensor system. Significantly, this approach allowed 
identification of proteins in serum at physiologically relevant concentrations using only five 
NP/GFP constructs. Furthermore, the sensor has potential in discriminating different 
concentrations of same protein and a mixture of proteins. Current studies are exploring the 
use of approach to the profiling of serum samples for the diagnosis of disease states.
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Green fluorescence protein (GFP) was expressed according to known procedure29. In brief, 
starter cultures from a glycerol stock of GFP in BL21(DE3) was grown overnight in 50 ml 
culture media at 37 °C. The following day, 5 ml of the starter cultures was added to a 
Fernbach flask containing 1 L culture media and shaken until the OD600 = 0.6 – 0.7. The 
culture was then induced by adding isopropyl-β-D-thiogalactopyranoside (IPTG) (1 mM 
final concentration) and shaken at 28 °C. After three hours, the cells were harvested by 
centrifugation and the pellet was then resuspended in lysis buffer. Once lysed, the solution 
was pelleted and the supernatant was further purified using HisPur Cobalt columns. The 
analyte proteins, serum albumin (HSA), immunoglobulins (IgG), transferrin, fibrinogen and 
α-antitrypsin all from human serum were purchased from Sigma-Aldrich and used as 
received. Cationic NPs NP1, NP2 were synthesized according to the reported procedure and 
NP3 – NP5 were prepared following the similar procedure which is elaborately described in 
supporting information. 5 mM sodium phosphate buffer, pH 7.4 was used as a solvent for 
the experiment in buffer solution. The commercial human serum from untransfused male 
donors was purchased from MP Biomedicals, LLC and used without further treatment.
In the fluorescence titration between NPs and GFP, the change of fluorescence intensity at 
510 nm was measured with an excitation wavelength of 475 nm at various concentrations of 
nanoparticles from 0 to 100 nM on a Molecular Devices SpectaMax M5 microplate reader at 
25 °C in 5 mM sodium phosphate buffer. The change of fluorescence intensity against 
increasing NP concentrations was plotted (Figure S2), using a non-interacting gold NP (e.g. 
PEG-NP) as a control to compensate for particle absorption. Nonlinear least-squares curve-
fitting analysis was employed to estimate the binding constant (Ks) and association 
stoichiometry (n) using the model in which the nanoparticle is assumed to possess n 
equivalent of independent binding sites. In case of human serum, similar procedure was 
followed, but the only modification was the concentration of GFP (250 nM) and the 
nanoparticles (0–2 μM).
To create the training matrix, GFP and NPs are mixed in the ratio obtained from 
fluorescence titration. In case of 5 mM sodium phosphate buffer solution the final 
concentration of NP and GFP were 100 nM each. On the other hand, in serum studies the 
final concentration of NP and GFP were 500 nM and 250 nM respectively. After 30 min of 
incubation 200 μL of each solution was loaded into a well on a 96-well plate (300 μL 
Whatman black bottom micropalte) and the fluorescence intensity at 510 nm recorded using 
fluorescence microplate reader (Molecular Devices SpectraMax M5). Subsequently, 10 μL 
of protein solution, 0.525 μM for buffer solution and 10.5 μM for serum solution, was added 
so that the final concentrations were 25 nM and 500 nM in buffer and serum respectively. 
After incubation for 30 min the fluorescence intensity at 510 nm was recorded again. The 
difference between the two intensities before and after addition of proteins was considered 
as the fluorescence response (Table S1 and S3). This process was repeated for five serum 
proteins with five selective cationic NP in six replicates. This data was used to generate the 
6 × 5 × 5 (6 replicates × 5 proteins × 5 NPs) training matrix. This training matrix was used 
for classical linear discriminant analysis (LDA) in SYSTAT (version 11.0).
DE et al. Page 5









For the unknown detection, we prepared the protein solutions (0.525 μM or 10.5 μM) out of 
the five serum proteins according to buffer or serum study. From this prepared solution we 
randomly choose 30 samples for each system (buffer or serum) and the same method was 
followed using the GFP-NP motif. We replicated each unknown samples three times instead 
of six for preparing training matrix. We considered the average response of three replicates 
for a single unknown sample and analyzed with five known proteins in LDA analysis.
Supplementary Material
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Figure 1. Structural features of nanoparticles (NPs) and modes of sensor response
(a) Chemical structures of cationic gold NPs. NP1 features primarily cationic charge, NP2 
and NP4 feature groups capable of hydrophobic interaction, NP3 features groups capable of 
hydrogen bonding and NP5 has aromatic recognition unit capable of π-π interaction. (b) 
Schematic illustration of the competitive binding between protein and quenched GFP-NP 
complexes and protein aggregation leading to the fluorescence light-up or further quenching.
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Figure 2. Array based sensing of five serum proteins in 5 mM sodium phosphate buffer (pH 7.40)
(a) Fluorescence response (ΔI) patterns of five GFP-NP adducts in the presence of five high 
abundant serum proteins at 25 nM concentration (responses are averages of six 
measurements and error bars are standard deviations). (b) Canonical score plot for the 
fluorescence patterns as obtained from LDA against five protein analytes at fixed 
concentration of 25 nM, with 95% confidence ellipses.
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Figure 3. Determination of the optimum ratio of fluorophore to NP
Change in fluorescence intensities of GFP (250 nM) at 510 nm were measured after the 
addition of cationic NPs (0–2 μM) with an excitation wavelength of 475 nm. The absorption 
effect from gold core was subtracted by using non-interacting tetra(ethylene glycol)-
functionalized gold NPs. Inset shows the change of Fluorescence intensity of GFP (100 nM) 
at 510 nm upon addition of cationic NP3 in 5 mM sodium phosphate buffer. The red solid 
lines represent the best curve fitting using the model of single set of identical binding sites 
and the arrow indicates the optimum binding ratio used for our study.
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Figure 4. Array based sensing of five serum proteins in human serum
(a) Fluorescence response (ΔI) pattern of five GFP-NP adducts in the presence of serum 
proteins spiked in human serum at 500 nM concentration (responses are average of six 
measurements and error bars are standard deviations of the measurements). (b) Canonical 
score plot for the fluorescence patterns as obtained from LDA against five protein analytes 
at fixed concentration (500 nM) with 95% confidence ellipses.
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Figure 5. Discrimination of HSA and IgG at different concentrations and mixture of proteins
(a) Canonical score plot for the fluorescence patterns as obtained from LDA for human 
serum albumin (HSA) and immunoglobulin G (IgG) at different concentrations (500 nM, 1 
μM and 2 μM) with 95% confidence ellipses. (b) Clustering of all the data for the three 
concentrations mentioned for each protein as obtained from LDA analysis. (c) HSA and IgG 
were mixed at 1:1 molar ratio with 250 nM each and 500 nM each and added to five GFP-
NP complexes. The canonical score plots obtained from LDA analysis were compared with 
that for the 500 nM of the individual proteins.
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Table 1
Molecular weight, isoelectric point and concentration of five analyte serum proteins26 in human serum.
Protein μML−1 Mwa pIb %c
Albumin 769 65 5.2 70
IgG 66.7 150 7.5–7.8 14
Transferrin 25–50 80 5.6 5.7
Fibrinogen 5.9 340 5.6 2.8
α-Antitrypsin 9.6 52 5.4 0.7
a) molecular weight in kDa
b) isoelectric point
c) weight percent in human serum.
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Table 2








aChange in protein concentrations in molarity.
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